Boxer Capital, LLC's Net Worth
$13.6 Billion
Who is Boxer Capital, LLC?
Boxer Capital, LLC has an estimated net worth of $13.6 Billion. This is based on reported shares across multiple companies, which include Mirati Therapeutics, Inc., Odonate Therapeutics, Inc., SOPHIRIS BIO INC., iTeos Therapeutics, Inc., PMV Pharmaceuticals, Inc., Tyra Biosciences, Inc., Tango Therapeutics, Inc., Esperion Therapeutics, Inc., Solid Biosciences Inc., Eleven Biotherapeutics, Inc., Pandion Therapeutics Holdco LLC, Rain Therapeutics Inc., Somaxon Pharmaceuticals, Inc., and ARADIGM CORP.
SEC CIK
Boxer Capital, LLC's CIK is 0001465837
Past Insider Trading and Trends
2020 was Boxer Capital, LLC's most active year for acquiring shares with 21 total transactions. Boxer Capital, LLC's most active month to acquire stocks was the month of September. 2019 was Boxer Capital, LLC's most active year for disposing of shares, totalling 20 transactions. Boxer Capital, LLC's most active month to dispose stocks was the month of December. 2023 saw Boxer Capital, LLC paying a total of $108,352,559.58 for 9,584,038 shares, this is the most they've acquired in one year. In 2020 Boxer Capital, LLC cashed out on 18,934,151 shares for a total of $83,040,276.71, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Odonate Therapeutics, Inc. (ODTC) Snapshot price: $3150
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.68% | -400.00K |
$1.56 | -$623,340.00 | 4.21M |
Nov 22 - Nov 24
| |||
Form 4
| -17.83% | -1.00M |
$2.06 | -$2,062,775.00 | 4.61M |
Nov 17 - Nov 19
| |||
Form 4
| +7.68% | 400K |
$17.16 | $6,863,427.50 | 5.61M |
Dec 28 - Dec 30
| |||
Form 4
| +4.31% | 215.2K |
$13.63 | $2,932,156.00 | 5.21M |
Sep 28 - Sep 29
| |||
Form 4
| +4.72% | 225K |
$14.99 | $3,371,631.00 | 4.99M |
Sep 4 - Sep 9
| |||
Form 4
| +41.73% | 1.4M |
$14.25 | $20,000,003.25 | 4.77M |
Aug 28
| |||
Form 4
| +12.91% | 384.62K |
$26.00 | $9,999,990.00 | 3.36M |
Jun 26
| |||
Form 4
| +4.38% | 125K |
$13.27 | $1,658,830.00 | 2.98M |
Dec 21 - Dec 26
| |||
Form 4
| +0.95% | 26.82K |
$14.72 | $394,752.71 | 2.85M |
Oct 24
| |||
Form 4
| +3.67% | 100K |
$22.73 | $2,273,153.36 | 2.83M |
Mar 22 - Mar 26
| |||
Form 4
| +18.04% | 416.67K |
$24.00 | $9,999,984.00 | 2.73M |
Dec 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SOPHIRIS BIO INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -34.41% | -881.48K |
$0.61 | -$537,702.19 | 1.68M |
Dec 15
| |||
Form 4
| +166.40% | 1.6M |
$5.00 | $8,000,000.00 | 2.56M |
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iTeos Therapeutics, Inc. (ITOS) Snapshot price: $14.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +63.35% | 1.14M |
$17.50 | $19,999,997.50 | 2.95M |
May 10
| |||
Form 4
| -16.25% | -350.00K |
$16.26 | -$5,692,672.88 | 1.8M |
Aug 23
| |||
Form 4
| -15.47% | -575.20K |
$35.25 | -$20,275,835.25 | 3.14M |
Mar 17
| |||
Form 4
| -8.41% | -700.00K |
$45.32 | -$32,575,642.35 | 7.62M |
Jan 3 - Jan 4
| |||
Form 4
| +147.62% | 4.42M |
$19.00 | $27,075,000.00 | 7.41M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.6588
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.33M |
$18.00 |
—
| 2.33M |
Sep 25 - Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirati Therapeutics, Inc. (MRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.86M |
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +56.45% | 1.26M |
$27.80 | $34,999,449.40 | 3.49M |
Aug 11
| |||
Form 4
| +56.45% | 1.26M |
$27.80 | $34,999,449.40 | 3.49M |
Aug 11
| |||
Form 4
| +10.47% | 211.44K |
$181.15 | -$72,460,293.56 | 2.23M |
Mar 5
| |||
Form 4
|
—
|
0
|
$207.99 | -$80,800,259.91 | 3.42M |
Oct 30
| |||
Form 4
| +2.91% | 50K |
$97.50 | $4,875,000.00 | 1.77M |
Jan 10
| |||
Form 4
|
—
|
0
|
$98.30 | -$71,267,602.59 | 1.72M |
Jul 17
| |||
Form 4
|
—
|
0
|
$69.00 | -$29,325,011.79 | 1.72M |
Mar 1
| |||
Form 4
| +9.58% | 150K |
$62.00 | $9,300,000.00 | 1.72M |
Jan 17
| |||
Form 4
|
—
|
0
|
$51.98 | -$36,389,203.57 | 1.57M |
Jan 8 - Jan 9
| |||
Form 4
| +14.07% | 193.05K |
$38.85 | $7,499,992.50 | 1.57M |
Jun 7
| |||
Form 4
| +9.74% | 400K |
$13.00 | $5,200,000.00 | 4.51M |
Nov 16
| |||
Form 4
| +18.19% | 267.97K |
$7.86 | $2,106,212.76 | 1.74M |
Oct 3
| |||
Form 4
| +18.19% | 267.97K |
$7.86 | $2,106,212.76 | 1.74M |
Oct 3
| |||
Form 4
| +24.10% | 286.16K |
$5.60 | $1,602,512.80 | 1.47M |
Jan 6
| |||
Form 4
| -38.48% | -474.16K |
—
|
—
| 757.93K |
Mar 16
| |||
Form 4
| -39.10% | -791.14K |
—
|
—
| 1.23M |
Jan 14
| |||
Form 4
| -100.00% | -522.50K |
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1.80% | 45K |
$45.00 | $2,025,000.00 | 2.55M |
Sep 16 - Sep 17
| |||
Form 4
| +28.19% | 550K |
$20.00 | $11,000,000.00 | 2.5M |
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +20.20% | 400K |
$17.50 | $7,000,000.00 | 2.38M |
Oct 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||